The McCAVE Trial : Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

Bendell, J C, Sauri, T, Gracian, A C, Alvarez, R, Lopez-Lopez, C, Garcia-Alfonso, P, Hussein, M, Limon Miron, M-L, Cervantes, A, Montagut, C, Santos Vivas, C, Bessudo, A, Plezia, P, Moons, V, Andel, J, Bennouna, J, van der Westhuizen, A, Samuel, L, Rossomanno, S, Boetsch, C, Lahr, A, Franjkovic, I, Heil, F, Lechner, K, Krieter, O & Hurwitz, H 2020, 'The McCAVE Trial : Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)', Oncologist, vol. 25, no. 3, pp. e451-e459. https://doi.org/10.1634/theoncologist.2019-0291